systemic scleroderma

GPTKB entity

Statements (45)
Predicate Object
gptkbp:instance_of gptkb:motorcycle
gptkbp:bfsLayer 3
gptkbp:bfsParent gptkb:motorcycle
gptkbp:affects gptkb:skincare_product
connective tissue
gptkbp:caused_by autoimmune response
gptkbp:clinical_trial stem cell therapy
biologics
new therapies
gptkbp:color gptkb:blue
gptkbp:complications pulmonary hypertension
interstitial lung disease
esophageal dysfunction
renal crisis
gptkbp:current_use gptkb:healthcare_organization
gptkb:rheumatoid_arthritis
thyroid disease
gptkbp:environmental_impact silica exposure
solvent exposure
gptkbp:genetic_diversity family history
specific gene mutations
gptkbp:historical_figure gptkb:Miriam_Makeba
gptkb:Paul_Klee
https://www.w3.org/2000/01/rdf-schema#label systemic scleroderma
gptkbp:is_involved_in gptkb:Scleroderma_Foundation
Scleroderma Research Foundation
gptkbp:is_popular_in more common in women
gptkbp:notable_event gptkb:Marlon_Brando
gptkb:Maya_Angelou
gptkb:The_Joan_Rivers
gptkbp:premiered_on 30 to 50 years
gptkbp:public_awareness gptkb:June
gptkbp:research_focus quality of life
treatment options
pathogenesis
gptkbp:social_responsibility blood tests
skin biopsy
gptkbp:symptoms gptkb:Raynaud's_phenomenon
fatigue
joint pain
shortness of breath
thickening of the skin
gptkbp:treatment physical therapy
corticosteroids
immunosuppressants